Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements. 

H.R.3 - Lower Drug Costs Now Act 
H.R.19 - Lower Costs, More Cures Act of 2019
H.R.259 - Medicaid Extenders Act of 2019 
H.R. 7647 - To provide for a COVID-19-related delay regarding annual limitation on cost-sharing for group health plans and individual and small group health insurance coverage
S.2543 - The Prescription Drug Pricing Reduction Act of 2019
S.3129 - Lower Costs, More Cures Act of 2019
H.R. 133 - Consolidated Appropriations Act, 2021 Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Education related to antivirals and oncology products. International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries. Administration's Buy American initiatives. Advocate on drug pricing proposals, expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. Highlighting Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatment for COVID-19 (2019 Novel Coronavirus), including: clinical trials, expanded access, compassionate use program, emergency use authorization, donation, distribution and allocation, and reimbursement of Veklury (remdesivir). 

H.R.6201 - Families First Coronavirus Response Act
S.3548 - CARES Act 
H.R.6800 - The Heroes Act 
H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S.3013 - Encouraging Innovate Benefit Design to Lower Costs for Seniors Act Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. 

H.R. 4378 - Continuing Appropriations Act and Health Extenders Act
H.R. 1865 - Further Consolidated Appropriations Act, 2020
H.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act
H.R. 8337 - Continuing Appropriations Act of 2021
H.R. 133 - Consolidated Appropriations Act, 2021
MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark VET - Veterans TRD - Trade (domestic/foreign) HCR - Health Issues BUD - Budget/Appropriations
134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 13 - Office of the Vice President of the United States 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI MICHAEL D BOYD ANNA GRIFFIN JENNIFER NIETO CAREY TERESA BILL (Special Asst. to the White House - Dept. of Interior; Senior Leg. Asst., Leg. Director, Deputy Chief of Staff, Chief of Staff - Rep. Larry Bucshon) DAVID PULLIAM CHARLES M. CLAPTON JENNIFER NIETO CAREY DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI DAVID PULLIAM CHARLES M. CLAPTON DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI MICHAEL D BOYD ANNA GRIFFIN JENNIFER NIETO CAREY TERESA BILL (Special Asst. to the White House - Dept. of Interior; Senior Leg. Asst., Leg. Director, Deputy Chief of Staff, Chief of Staff - Rep. Larry Bucshon) DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI JENNIFER NIETO CAREY TERESA BILL (Special Asst. to the White House - Dept. of Interior; Senior Leg. Asst., Leg. Director, Deputy Chief of Staff, Chief of Staff - Rep. Larry Bucshon)
Special Asst. to the White House - Dept. of Interior; Senior Leg. Asst., Leg. Director, Deputy Chief of Staff, Chief of Staff - Rep. Larry Bucshon Special Asst. to the White House - Dept. of Interior; Senior Leg. Asst., Leg. Director, Deputy Chief of Staff, Chief of Staff - Rep. Larry Bucshon Special Asst. to the White House - Dept. of Interior; Senior Leg. Asst., Leg. Director, Deputy Chief of Staff, Chief of Staff - Rep. Larry Bucshon